VRSNVERISIGN INC/CA

Nasdaq verisign.com


$ 175.50 $ -7.20 (-3.94 %)    

Friday, 26-Apr-2024 15:59:56 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 175.48
$ 178.62
$ 0.00 x 0
$ 0.00 x 0
$ 174.58 - $ 181.54
$ 174.51 - $ 229.72
1,931,523
na
17.71B
$ 0.85
$ 21.26
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-25-2024 03-31-2024 10-Q
2 02-15-2024 12-31-2023 10-K
3 10-26-2023 09-30-2023 10-Q
4 07-27-2023 06-30-2023 10-Q
5 04-27-2023 03-31-2023 10-Q
6 02-17-2023 12-31-2022 10-K
7 10-27-2022 09-30-2022 10-Q
8 07-28-2022 06-30-2022 10-Q
9 04-28-2022 03-31-2022 10-Q
10 02-18-2022 12-31-2021 10-K
11 10-28-2021 09-30-2021 10-Q
12 07-22-2021 06-30-2021 10-Q
13 04-22-2021 03-31-2021 10-Q
14 02-19-2021 12-31-2020 10-K
15 10-22-2020 09-30-2020 10-Q
16 07-23-2020 06-30-2020 10-Q
17 04-23-2020 03-31-2020 10-Q
18 02-14-2020 12-31-2019 10-K
19 10-25-2019 09-30-2019 10-Q
20 07-25-2019 06-30-2019 10-Q
21 04-25-2019 03-31-2019 10-Q
22 02-15-2019 12-31-2018 10-K
23 10-25-2018 09-30-2018 10-Q
24 07-26-2018 06-30-2018 10-Q
25 04-26-2018 03-31-2018 10-Q
26 02-16-2018 12-31-2017 10-K
27 10-26-2017 09-30-2017 10-Q
28 07-27-2017 06-30-2017 10-Q
29 04-27-2017 03-31-2017 10-Q
30 02-17-2017 12-31-2016 10-K
31 10-27-2016 09-30-2016 10-Q
32 07-28-2016 06-30-2016 10-Q
33 04-28-2016 03-31-2016 10-Q
34 02-19-2016 12-31-2015 10-K
35 10-22-2015 09-30-2015 10-Q
36 07-23-2015 06-30-2015 10-Q
37 04-23-2015 03-31-2015 10-Q
38 02-13-2015 12-31-2014 10-K
39 10-23-2014 09-30-2014 10-Q
40 07-24-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 baird-maintains-neutral-on-verisign-lowers-price-target-to-200

Baird analyst Robert Oliver maintains VeriSign (NASDAQ:VRSN) with a Neutral and lowers the price target from $215 to $200.

 verisign-q1-adj-192-beats-186-estimate-sales-38430m-beat-38185m-estimate

VeriSign (NASDAQ:VRSN) reported quarterly earnings of $1.92 per share which beat the analyst consensus estimate of $1.86 by 3.2...

 citigroup-maintains-buy-on-verisign-lowers-price-target-to-236

Citigroup analyst Ygal Arounian maintains VeriSign (NASDAQ:VRSN) with a Buy and lowers the price target from $237 to $236.

 verisign-q4-eps-260-beats-186-estimate-sales-38040m-beat-37787m-estimate

VeriSign (NASDAQ:VRSN) reported quarterly earnings of $2.60 per share which beat the analyst consensus estimate of $1.86 by 39....

 sp-500-tests-resistance-at-5000-arm-rockets-oil-rebounds-whats-driving-markets-thursday

Major U.S. stock averages traded on a mixed note at midday in New York, with the S&P 500 grappling with the psychological r...

 us-stocks-on-backfoot-amid-overbought-levels-sp-500-eyes-break-above-5k-analyst-sees-dramatically-higher-market-surge-from-rally-this-year

Focus now shifts to the jobless claims report for labor market insights, with market overbought levels prompting a defensive st...

 earnings-scheduled-for-february-8-2024

Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share ...

 preview-verisigns-earnings
Preview: VeriSign's Earnings
02/07/2024 18:01:15

 alphabet-coinbase-global-and-2-other-stocks-insiders-are-selling

The Nasdaq 100 closed higher by over 200 points on Thursday. Investors, meanwhile, focused on some notable insider trades.

 goldman-sachs-verisign-and-2-other-stocks-insiders-are-selling

The Nasdaq 100 closed lower by around 0.1% on Friday. Investors, meanwhile, focused on some notable insider trades.

 buffetts-berkshire-trimmed-chevron-stake-while-cashing-out-of-gm-and-this-covid-stock-heres-how-the-sage-of-omaha-adjusted-his-portfolio-in-q3

Buffett's Berkshire Hathaway held its core holdings largely unchanged in the third quarter but it made some portfolio moves...

 earnings-scheduled-for-october-26-2023

Companies Reporting Before The Bell • TotalEnergies (NYSE:TTE) is likely to report quarterly earnings at $2.57 per share on re...

 verisign-q2-eps-179-beats-175-estimate-sales-37200m-miss-37310m-estimate

VeriSign (NASDAQ:VRSN) reported quarterly earnings of $1.79 per share which beat the analyst consensus estimate of $1.75 by 2.2...

 earnings-scheduled-for-july-27-2023

Companies Reporting Before The Bell • SES AI (NYSE:SES) is projected to report quarterly earnings at $0.11 per share on revenu...

 verisigns-earnings-outlook
VeriSign's Earnings Outlook
07/26/2023 19:01:47

 citigroup-maintains-buy-on-verisign-lowers-price-target-to-249

Citigroup analyst Ygal Arounian maintains VeriSign (NASDAQ:VRSN) with a Buy and lowers the price target from $252 to $249.

 citigroup-maintains-buy-on-verisign-lowers-price-target-to-249

Citigroup analyst Ygal Arounian maintains VeriSign (NASDAQ:VRSN) with a Buy and lowers the price target from $252 to $249.

 why-siyata-mobile-shares-are-trading-lower-by-21-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares climbed 129.5% to $8.01 after gaining 9% on Monday.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION